GenVec, TheraBiologics to develop new cancer therapeutics
The new cancer therapeutics will be developed using both GenVec’s gene delivery platform and TheraBiologics’ neural stem cell (NSC) technology. Under the deal, GenVec will contribute technology, know-how,